background image

Clinical Trials In Austin

Discover hundreds of clinical trials in Austin.
Search clinical trials in Austin by condition or phase.

e.g. Respiratory Diseases
AustinHealthy volunteers: No

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Austin, Richmond, The Woodlands, Houstonshow 42 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Kyle, Tomball, Houston, Kingwoodshow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Austin, San Antonio, Houston, Fort Worthshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Recruiting
PHASE3

Sponsor:

Amneal Pharmaceuticals, LLC

Location:

Austin, Houston, Nashville, Morrowshow 5 more

Code:

NCT05401357

Conditions

Glaucoma, Open-Angle

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Test - Bimatoprost 0.01% Ophthalmic Solution

Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Austin, San Antonio, Houston, Fort Worthshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Recruiting
PHASE1
PHASE2

Sponsor:

AbbVie

Location:

Austin, Oklahoma City, Kansas City, Chesterfieldshow 27 more

Code:

NCT04499248

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AGN-193408 SR

Lumigan

Sham Administration

Lumigan Vehicle

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Recruiting

Sponsor:

University of Kansas Medical Center

Location:

Austin, Houston, Kansas City, Bloomingtonshow 7 more

Code:

NCT06425848

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Observational

Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

Recruiting

Sponsor:

Massachusetts General Hospital

Location:

Austin, Jonesboro, Cleveland, New Yorkshow 1 more

Code:

NCT06099730

Conditions

Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pulsed Field Ablation (PFA)

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children with Recurrent Wheezing

Recruiting
PHASE2

Sponsor:

OM Pharma SA

Location:

Pflugerville, San Antonio, Houston, Mansfieldshow 24 more

Code:

NCT05857930

Conditions

Recurrent Wheezing

Wheezing Lower Respiratory Illness

Eligibility Criteria

Sex: All

Age: 6 - 70+

Healthy Volunteers: Not accepted

Interventions

OM-85

Placebo

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Recruiting
PHASE3

Sponsor:

Madrigal Pharmaceuticals, Inc.

Location:

Austin, Georgetown, San Antonio, Wacoshow 45 more

Code:

NCT05500222

Conditions

NASH

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Resmetirom

Placebo

With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.

Why choose Austin for clinical trials?

Common conditions studied in Austin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Austin